Credit rating
Company information
About Kripthonite Therapeutics ApS
Kripthonite Therapeutics ApS (CVR number: 43770209) is a company from RUDERSDAL. The company recorded a gross profit of 541.6 kDKK in 2023. The operating profit was -4.6 kDKK, while net earnings were -5.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -6.1 %, which can be considered poor and Return on Equity (ROE) was -15.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 46 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Kripthonite Therapeutics ApS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2023 | |
---|---|
Volume | |
Net sales | |
Gross profit | 541.64 |
EBIT | -4.57 |
Net earnings | -5.41 |
Shareholders equity total | 34.59 |
Balance sheet total (assets) | 75.12 |
Net debt | -30.08 |
Profitability | |
EBIT-% | |
ROA | -6.1 % |
ROE | -15.6 % |
ROI | -13.2 % |
Economic value added (EVA) | -4.57 |
Solvency | |
Equity ratio | 46.0 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 1.9 |
Current ratio | 1.9 |
Cash and cash equivalents | 30.08 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | C |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.